Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

IRTC

iRhythm Holdings Inc

Feb 12 • 02:39PM ET

152.17

+0.06 0.04 %

Healthcare • Medical Devices • USA • NASD

Peers: ISRG DXCM TDOC ALGN VEEV BIO PODD STM QDEL JAZZ

| Held by: VTI VB IWM VBK VXF IWO VTWO SCHA IHI VHT

Index	RUT	P/E	-	EPS (ttm)	-1.62	Insider Own	1.63%	Shs Outstand	32.20M	Perf Week	3.70%
Market Cap	4.90B	Forward P/E	-	EPS next Y	-0.49	Insider Trans	-7.41%	Shs Float	31.69M	Perf Month	-2.10%
Enterprise Value	5.07B	PEG	-	EPS next Q	0.01	Inst Own	106.06%	Short Float	8.93%	Perf Quarter	-13.69%
Income	-51.46M	P/S	6.98	EPS this Y	58.63%	Inst Trans	-3.38%	Short Ratio	4.91	Perf Half Y	-8.80%
Sales	702.57M	P/B	40.21	EPS next Y	67.64%	ROA	-5.40%	Short Interest	2.83M	Perf YTD	-14.24%
Book/sh	3.78	P/C	8.67	EPS next 5Y	-	ROE	-53.15%	52W High	212.00 -28.22%	Perf Year	36.88%
Cash/sh	17.54	P/FCF	151.23	EPS past 3/5Y	-1.67% -10.95%	ROIC	-6.14%	52W Low	92.52 64.48%	Perf 3Y	46.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.39% 22.50%	Gross Margin	70.35%	Volatility	4.43% 4.98%	Perf 5Y	-11.71%
Dividend TTM	-	EV/Sales	7.22	EPS Y/Y TTM	66.62%	Oper. Margin	-7.77%	ATR (14)	7.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.50	Sales Y/Y TTM	25.45%	Profit Margin	-7.32%	RSI (14)	42.14	Recom	1.19
Dividend Gr. 3/5Y	- -	Current Ratio	4.63	EPS Q/Q	89.03%	SMA20	-2.91%	Beta	1.08	Target Price	221.27
Payout	-	Debt/Eq	6.01	Sales Q/Q	30.74%	SMA50	-9.39%	Rel Volume	0.82	Prev Close	152.11
Employees	2000	LT Debt/Eq	5.88	Earnings	Feb 19 AMC	SMA200	-5.78%	Avg Volume	576.72K	Price	152.17
IPO	Oct 20, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	50.65% 4.39%	Trades		Volume	377,537	Change	0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform	$210
Sep-23-25	Initiated	Evercore ISI	In-line	$185
Aug-20-25	Initiated	BofA Securities	Buy	$200
May-02-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$130
Dec-03-24	Resumed	Wells Fargo	Equal Weight	$86
Oct-04-24	Initiated	Goldman	Neutral	$78
Jun-20-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$115
Dec-11-23	Upgrade	Citigroup	Neutral → Buy	$110
Jul-19-23	Initiated	Robert W. Baird	Outperform	$130
Feb-07-23	Initiated	Wells Fargo	Overweight	$150
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral	$180 → $155
Apr-06-22	Initiated	Wolfe Research	Underperform	$105
Feb-24-22	Upgrade	Needham	Hold → Buy	$135
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$129 → $167
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy	$170
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform	$150
Dec-21-21	Resumed	Canaccord Genuity	Buy	$125
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight	$100 → $116

Show Previous Ratings

Feb-05-26 04:30PM	iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 (GlobeNewswire)
Feb-04-26 11:36PM	2 Healthcare Stocks with Promising Prospects and 1 We Brush Off (StockStory) -5.48%
Jan-30-26 02:31PM	Here is Why Hedge Funds Are Appreciating iRhythm Holdings (IRTC) (Insider Monkey)
08:57AM	Owlet Strengthens Healthcare Partnerships: Can Adoption Scale? (Zacks)
Jan-29-26 05:02PM	HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
10:34PM	Loading…
Jan-20-26 10:34PM	Patient Monitoring Stocks Q3 Earnings: iRhythm (NASDAQ:IRTC) Best of the Bunch (StockStory)
12:08PM	Owlet Broadens Its Product Ecosystem: Can New Devices Drive Growth? (Zacks)
Jan-15-26 11:22AM	Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire) +5.39%
06:53AM	IRHYTHM HLDGS (IRTC) Moves 5.0% Higher: Will This Strength Last? (Zacks)
Jan-14-26 12:43PM	iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst (Benzinga) +5.02%
09:57AM	Owlet Gains From FDA Clarity: Does Regulation Create an Edge? (Zacks)
Jan-13-26 07:43AM	iRhythm sees FY26 revenue $870M-$880M, consensus $862.68M (TipRanks) -8.02%
Jan-12-26 04:18PM	JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won (Investor's Business Daily) -5.82%
08:26AM	Owlet Stock Up More Than 82% in the Past 6 Months: Still Worth Buying? (Zacks)
07:30AM	iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
11:05PM	Loading…
Jan-07-26 11:05PM	2 Reasons to Like IRTC (and 1 Not So Much) (StockStory)
Dec-29-25 04:30PM	iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-25 03:01PM	Why iRhythm (IRTC) Stock Is Up Today (StockStory)
09:53AM	Morgan Stanley Raises iRhythm (IRTC) PT on MedTech Recovery Outlook (Insider Monkey)
Dec-05-25 02:25PM	HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
10:22AM	1 Mooning Stock with Promising Prospects and 2 Facing Challenges (StockStory)
Nov-30-25 03:18PM	HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-21-25 08:10AM	New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm's Zio Long-Term Continuous Monitoring in an Asian Population (GlobeNewswire)
Nov-11-25 08:05AM	iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025 (GlobeNewswire)
Nov-06-25 12:38AM	5 Must-Read Analyst Questions From iRhythm's Q3 Earnings Call (StockStory)
Nov-05-25 01:38PM	iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating (Barrons.com)
Nov-04-25 04:30PM	iRhythm Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-25 07:35PM	Closing Bell Movers: Amazon soars to all-time highs on earnings (TipRanks)
01:01PM	Why iRhythm (IRTC) Stock Is Trading Up Today (StockStory)
08:40AM	IRTC Q3 Deep Dive: New Account Growth and AI Partnerships Fuel Guidance Raise (StockStory)
11:03PM	Loading…
Oct-30-25 11:03PM	iRhythm Technologies Inc (IRTC) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
05:45PM	iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:18PM	iRhythm (NASDAQ:IRTC) Beats Expectations in Strong Q3, Stock Soars (StockStory)
04:05PM	iRhythm Technologies Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-28-25 11:13PM	iRhythm Earnings: What To Look For From IRTC (StockStory)
Oct-23-25 05:00PM	Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Oct-20-25 06:31AM	iRhythm Technologies (IRTC) Leads Cardiac Monitoring Market with Zio Device, Freedom Capital Initiates Coverage (Insider Monkey)
Oct-16-25 04:30PM	iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025 (GlobeNewswire)
Oct-05-25 11:35PM	Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks (StockStory)
Oct-01-25 12:32AM	1 Cash-Producing Stock with Competitive Advantages and 2 We Question (StockStory)
Sep-30-25 12:35PM	iRhythm Technologies, Inc. (IRTC) Shares Surge 96% Despite FDA Warning and Legal Challenges (Insider Monkey)
Sep-23-25 09:40AM	CoreWeave upgraded, Lululemon downgraded: Wall Street's top analyst calls (The Fly) -5.02%
Sep-12-25 08:34AM	IRhythm Technologies (IRTC) Surged on Continued Momentum in Mobile Cardiac Telemetry (Insider Monkey)
Sep-11-25 12:39AM	3 Overrated Stocks with Open Questions (StockStory)
Sep-02-25 01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
Sep-01-25 12:01AM	iRhythm (IRTC): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-29-25 07:00AM	AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service (GlobeNewswire)
Aug-22-25 09:03AM	Solid Earnings Lifted iRhythm Technologies (IRTC) in Q2 (Insider Monkey)
Aug-20-25 04:30PM	iRhythm Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
12:34AM	iRhythm Technologies (IRTC) Surpasses Q2 Revenue Forecasts, Raises Outlook (Insider Monkey)
Aug-18-25 09:00AM	Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC) (Business Wire)
08:05AM	AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority (GlobeNewswire)
Aug-13-25 03:00PM	Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? (Zacks)
12:08AM	IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook (StockStory)
12:05AM	5 Must-Read Analyst Questions From iRhythm's Q2 Earnings Call (StockStory)
Aug-01-25 12:21PM	iRhythm (IRTC) Stock Trades Up, Here Is Why (StockStory) +17.68%
03:37AM	iRhythm Technologies Inc (IRTC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Jul-31-25 05:40PM	iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:54PM	iRhythm (NASDAQ:IRTC) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:10PM	iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions (GlobeNewswire)
04:05PM	iRhythm Technologies Announces Second Quarter 2025 Financial Results (GlobeNewswire)
12:33PM	FDA Clearance Boosts iRhythm Zio Device Innovation and Fuels Growth Potential (Insider Monkey)
Jul-29-25 11:11PM	What To Expect From iRhythm's (IRTC) Q2 Earnings (StockStory)
Jul-28-25 10:00AM	Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-24-25 10:00AM	Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-23-25 08:44AM	Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum (Zacks)
Jul-17-25 04:30PM	iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 (GlobeNewswire)
03:00PM	TEM Shares Surge on New AI Breakthrough: Should Investors Jump In? (Zacks)
Jul-15-25 08:45AM	Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity (PR Newswire)
Jul-14-25 03:21PM	iRhythm (IRTC) Stock Trades Up, Here Is Why (StockStory)
Jul-11-25 01:34AM	5 Revealing Analyst Questions From iRhythm's Q1 Earnings Call (StockStory)
Jul-10-25 04:52PM	Integer Appoints Michael Coyle to Board of Directors (GlobeNewswire)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire)
Jun-29-25 11:32PM	Patient Monitoring Stocks Q1 In Review: iRhythm (NASDAQ:IRTC) Vs Peers (StockStory)
Jun-27-25 12:03AM	3 Reasons IRTC is Risky and 1 Stock to Buy Instead (StockStory)
Jun-23-25 08:30AM	New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease (GlobeNewswire)
Jun-19-25 07:21AM	DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health? (Zacks)
Jun-09-25 03:00PM	Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? (Zacks)
May-21-25 04:45PM	iRhythm Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-16-25 06:45AM	IRTC Q1 Earnings Call: Outperformance Driven by Zio AT and Primary Care Channel Expansion (StockStory)
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
May-11-25 05:25PM	Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now (Insider Monkey)
May-06-25 03:20PM	Veracyte Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
May-05-25 02:48PM	Progyny Stock Sees RS Rating Improve To 73 (Investor's Business Daily)
May-02-25 03:17AM	iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com) +20.75%
May-01-25 09:14PM	iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:45PM	IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:10PM	iRhythm Launches Zio Long-Term Continuous Monitoring Service in Japan as the Zio ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection (GlobeNewswire)
04:05PM	iRhythm Technologies Announces First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 06:05PM	iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
Apr-28-25 08:05AM	iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring (GlobeNewswire)
Apr-25-25 04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks)
Apr-17-25 04:30PM	iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 (GlobeNewswire)
Apr-16-25 08:35AM	iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability (GlobeNewswire)
Apr-10-25 05:05AM	3 Reasons IRTC is Risky and 1 Stock to Buy Instead (StockStory)
Apr-03-25 05:09AM	Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks (StockStory)
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
Mar-31-25 08:05AM	iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio Long-Term Continuous Monitoring for Arrhythmia Detection (GlobeNewswire)
Mar-17-25 12:00PM	iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know (Zacks)

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Patterson Chad	CHIEF COMM & PRODUCT OFFICER	Dec 02 '25	Sale	184.83	280	51,752	43,387	Dec 03 04:35 PM
Murphy Patrick Michael	CBO and CLO	Dec 02 '25	Sale	184.83	2,478	458,009	53,281	Dec 03 04:35 PM
CHAD PATTERSON	Officer	Dec 02 '25	Proposed Sale	184.83	280	51,752		Dec 02 04:01 PM
TALWALKAR ABHIJIT Y	Director	Nov 10 '25	Option Exercise	10.71	5,312	56,892	25,611	Nov 12 04:33 PM
TALWALKAR ABHIJIT Y	Director	Nov 10 '25	Sale	174.13	5,312	924,962	20,299	Nov 12 04:33 PM
ABHIJIT Y TALWALKAR	Director	Nov 10 '25	Proposed Sale	174.13	5,312	924,962		Nov 10 04:02 PM
Blackford Quentin S.	President and CEO	Nov 03 '25	Sale	182.94	14,059	2,571,907	164,979	Nov 04 05:04 PM
Wilson Daniel G.	Chief Financial Officer	Oct 31 '25	Sale	207.44	8,000	1,659,520	26,470	Nov 03 04:30 PM
DANIEL WILSON	Officer	Oct 31 '25	Proposed Sale	207.44	8,000	1,659,520		Oct 31 04:07 PM
Wilson Daniel G.	Chief Financial Officer	Sep 03 '25	Sale	175.00	5,000	875,000	34,470	Sep 04 05:14 PM
Wilson Daniel G.	Chief Financial Officer	Sep 02 '25	Sale	167.28	737	123,285	39,470	Sep 03 04:30 PM
DANIEL WILSON	Officer	Sep 03 '25	Proposed Sale	175.00	5,000	875,000		Sep 03 04:16 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Aug 22 '25	Sale	167.12	653	109,129	34,032	Aug 22 06:27 PM
SUMI SHRISHRIMAL	Officer	Aug 22 '25	Proposed Sale	167.12	653	109,129		Aug 22 04:02 PM
Rosenbaum Marc Wade	Chief Accounting Officer	Aug 11 '25	Sale	158.93	226	35,918	10,879	Aug 12 04:39 PM
TALWALKAR ABHIJIT Y	Director	Aug 11 '25	Option Exercise	10.71	5,312	56,892	25,611	Aug 12 04:38 PM
TALWALKAR ABHIJIT Y	Director	Aug 11 '25	Sale	158.02	5,312	839,381	20,299	Aug 12 04:38 PM
ABHIJIT Y TALWALKAR	Director	Aug 11 '25	Proposed Sale	158.02	5,312	839,380		Aug 11 04:18 PM
MARC ROSENBAUM	Officer	Aug 11 '25	Proposed Sale	158.93	226	35,918		Aug 11 04:04 PM
Patterson Chad	Chief Commercial Officer	Aug 06 '25	Sale	158.97	2,555	406,168	43,667	Aug 07 04:57 PM
Blackford Quentin S.	President and CEO	Aug 05 '25	Sale	160.54	30,000	4,816,191	179,038	Aug 06 05:10 PM
CHAD PATTERSON	Officer	Aug 06 '25	Proposed Sale	158.97	2,555	406,168		Aug 06 04:05 PM
QUENTIN BLACKFORD	Officer	Aug 05 '25	Proposed Sale	160.54	30,000	4,816,191		Aug 05 05:06 PM
Smith Mervin	EVP Strategic Business Ops	Aug 04 '25	Sale	164.36	616	101,246	15,838	Aug 05 05:03 PM
Patterson Chad	Chief Commercial Officer	Aug 04 '25	Sale	164.36	2,707	444,922	46,222	Aug 05 05:02 PM
MARK JEFFREY RUBASH	Director	Aug 05 '25	Proposed Sale	160.54	15,000	2,408,109		Aug 05 04:51 PM
Turakhia Minang	EVP, CMO & CSO	Jul 02 '25	Sale	145.41	1,420	206,482	41,393	Jul 02 05:51 PM
Wilson Daniel G.	Chief Financial Officer	Jun 23 '25	Sale	150.00	3,000	450,000	40,307	Jun 24 04:16 PM
Patterson Chad	Chief Commercial Officer	Jun 23 '25	Sale	150.00	936	140,400	48,929	Jun 24 04:15 PM
DANIEL WILSON	Officer	Jun 23 '25	Proposed Sale	150.00	3,000	450,000		Jun 23 04:36 PM
CHAD PATTERSON	Officer	Jun 23 '25	Proposed Sale	150.00	936	140,400		Jun 23 04:13 PM
Patterson Chad	Chief Commercial Officer	Jun 10 '25	Sale	150.00	363	54,450	49,865	Jun 11 04:21 PM
CHAD PATTERSON	Officer	Jun 10 '25	Proposed Sale	150.00	363	54,450		Jun 10 06:06 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Jun 02 '25	Sale	140.21	1,608	225,458	34,685	Jun 03 04:18 PM
Rosenbaum Marc W.	Chief Accounting Officer	Jun 02 '25	Sale	140.21	696	97,586	11,105	Jun 03 04:17 PM
Wilson Daniel G.	Chief Financial Officer	May 02 '25	Sale	125.00	2,000	250,000	43,307	May 05 04:11 PM
Patterson Chad	Chief Commercial Officer	May 02 '25	Sale	120.55	8,510	1,025,898	49,930	May 05 04:10 PM
DANIEL WILSON	Officer	May 02 '25	Proposed Sale	125.00	2,000	250,000		May 02 04:14 PM
CHAD PATTERSON	Officer	May 02 '25	Proposed Sale	120.55	8,510	1,025,898		May 02 04:13 PM
Blackford Quentin S.	President and CEO	Mar 03 '25	Sale	108.77	8,145	885,932	208,741	Mar 04 04:05 PM
Rosenbaum Marc W.	Chief Accounting Officer	Mar 03 '25	Sale	108.77	314	34,154	11,507	Mar 04 04:05 PM
Smith Mervin	EVP Strategic Business Ops	Mar 03 '25	Sale	108.77	638	69,395	16,454	Mar 04 04:04 PM
Patterson Chad	Chief Commercial Officer	Mar 03 '25	Sale	108.77	2,756	299,770	58,440	Mar 04 04:03 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Mar 03 '25	Sale	108.77	1,726	187,737	36,117	Mar 04 04:02 PM
Turakhia Minang	EVP, CMO & CSO	Mar 03 '25	Sale	108.77	2,467	268,336	42,495	Mar 04 04:02 PM
Wilson Daniel G.	Chief Financial Officer	Mar 03 '25	Sale	108.77	2,341	254,631	45,307	Mar 04 04:01 PM
Patterson Chad	Chief Commercial Officer	Feb 26 '25	Sale	112.13	13,229	1,483,368	61,196	Feb 27 04:08 PM
Patterson Chad	Chief Commercial Officer	Feb 25 '25	Sale	118.98	461	54,850	36,761	Feb 27 04:08 PM
Shrishrimal Sumi	EVP, Chief Risk Officer	Feb 26 '25	Sale	112.13	7,942	890,536	37,843	Feb 27 04:07 PM
Turakhia Minang	EVP, CMO & CSO	Feb 26 '25	Sale	112.13	7,014	786,480	44,962	Feb 27 04:06 PM
Murphy Patrick Michael	CBO and CLO	Feb 26 '25	Sale	109.68	16,330	1,791,041	58,834	Feb 27 04:04 PM
Blackford Quentin S.	President and CEO	Feb 26 '25	Sale	112.13	22,252	2,495,117	216,886	Feb 27 04:03 PM
Wilson Daniel G.	Chief Financial Officer	Feb 26 '25	Sale	112.13	2,512	281,671	47,648	Feb 27 04:03 PM
CHAD PATTERSON	Officer	Feb 25 '25	Proposed Sale	118.98	461	54,850		Feb 25 04:00 PM

Open in Screener

DXCM

Dexcom Inc

Feb 12 • 02:39PM ET

65.87

-2.28 -3.35 %

Healthcare • Medical Devices • USA • NASD

Peers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC

| Held by: VTI VOO QQQ VO IVV VUG SPY VOT XLV IWP

Index	NDX, S&P 500	P/E	36.66	EPS (ttm)	1.80	Insider Own	1.50%	Shs Outstand	390.00M	Perf Week	-5.75%
Market Cap	25.69B	Forward P/E	26.70	EPS next Y	2.47	Insider Trans	0.00%	Shs Float	384.15M	Perf Month	-6.23%
Enterprise Value	24.94B	PEG	1.21	EPS next Q	0.65	Inst Own	94.15%	Short Float	4.04%	Perf Quarter	13.31%
Income	720.70M	P/S	5.69	EPS this Y	25.62%	Inst Trans	-0.34%	Short Ratio	2.90	Perf Half Y	-17.62%
Sales	4.52B	P/B	9.42	EPS next Y	19.72%	ROA	10.40%	Short Interest	15.50M	Perf YTD	-0.75%
Book/sh	6.99	P/C	7.73	EPS next 5Y	22.04%	ROE	30.63%	52W High	93.25 -29.36%	Perf Year	-21.46%
Cash/sh	8.52	P/FCF	24.19	EPS past 3/5Y	41.20% 39.06%	ROIC	17.70%	52W Low	54.11 21.73%	Perf 3Y	-44.13%
Dividend Est.	-	EV/EBITDA	24.40	Sales past 3/5Y	18.10% 22.27%	Gross Margin	59.37%	Volatility	3.07% 3.13%	Perf 5Y	-36.14%
Dividend TTM	-	EV/Sales	5.52	EPS Y/Y TTM	5.66%	Oper. Margin	17.22%	ATR (14)	2.31	Perf 10Y	369.49%
Dividend Ex-Date	-	Quick Ratio	1.38	Sales Y/Y TTM	14.21%	Profit Margin	15.96%	RSI (14)	33.00	Recom	1.52
Dividend Gr. 3/5Y	- -	Current Ratio	1.56	EPS Q/Q	109.87%	SMA20	-7.42%	Beta	1.49	Target Price	86.15
Payout	0.00%	Debt/Eq	0.94	Sales Q/Q	21.64%	SMA50	-4.24%	Rel Volume	0.98	Prev Close	68.15
Employees	10300	LT Debt/Eq	0.49	Earnings	Feb 12 AMC	SMA200	-11.22%	Avg Volume	5.35M	Price	65.87
IPO	Apr 14, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.85% 2.16%	Trades		Volume	4,192,582	Change	-3.35%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-26	Downgrade	Barclays	Equal Weight → Underweight	$71
Dec-02-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$75
Nov-25-25	Initiated	Evercore ISI	In-line	$68
Oct-21-25	Resumed	Stifel	Buy	$85
Sep-08-25	Downgrade	Oppenheimer	Outperform → Perform
Aug-21-25	Initiated	Argus	Buy	$100
Jun-16-25	Initiated	Truist	Buy	$102
May-30-25	Initiated	Goldman	Buy	$104
Apr-10-25	Initiated	Mizuho	Outperform	$85
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103

Show Previous Ratings

Feb-11-26 11:00AM	Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM (Zacks)
09:31AM	What Are Wall Street Analysts' Target Price for DexCom Stock? (Barchart)
Feb-10-26 10:12PM	Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow (StockStory)
01:30PM	Baxter to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
11:22AM	Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth? (Zacks)
10:00AM	Loading…
10:00AM	Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
09:15AM	Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Feb-09-26 11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
10:24AM	WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins? (Zacks)
Feb-06-26 07:42AM	Wearables future in healthcare likely to hinge on actionable insights (Medical Device Network)
Feb-05-26 12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
10:00AM	DexCom (DXCM) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-04-26 01:55PM	Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings (Zacks)
09:45AM	DexCom (DXCM) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:30AM	Loading…
08:30AM	Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management (Business Wire)
Feb-03-26 11:31AM	GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy? (Zacks)
09:28AM	Should You Buy, Sell, or Hold McKesson Before Q3 Earnings? (Zacks)
Jan-30-26 02:31PM	Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive (Insider Monkey)
05:00AM	Senseonics wins CE mark for one-year CGM (MedTech Dive)
Jan-29-26 05:00PM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
12:51PM	Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery? (Zacks)
08:33AM	Can Specialty and International Momentum Support Cencora's Q1 Results? (Zacks)
Jan-28-26 11:33PM	3 Former Stock Picks Are Quietly Flashing Buy Signals Again (Barrons.com)
09:50AM	Here's Why DexCom (DXCM) is a Strong Momentum Stock (Zacks)
08:24AM	SYK's Q4 Results Likely to Reflect Procedure Growth and Capital Demand (Zacks)
Jan-27-26 12:59PM	HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes (Zacks)
08:38AM	Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments (Insider Monkey)
08:30AM	Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time. (Business Wire)
08:04AM	Could 2026 Be Dexcom's 'Get Right' Year? New CEO Jake Leach Says Yes. (Investor's Business Daily)
07:30PM	Loading…
Jan-23-26 07:30PM	Analyst Report: DexCom, Inc. (Morningstar Research)
08:48AM	Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock? (Zacks)
Jan-22-26 08:59PM	Analyst Report: DexCom, Inc. (Morningstar Research)
Jan-21-26 04:35PM	1 Growth Stock Down 19% to Buy Right Now (Motley Fool)
Jan-16-26 12:42PM	DexCom Stock Declines Following Strong Preliminary Q4 Results (Zacks)
09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:06PM	Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
07:16AM	DexCom's Q4 2025 Earnings: What to Expect (Barchart)
Jan-14-26 10:57AM	DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025 (Insider Monkey)
Jan-13-26 06:13PM	Watch CNBC's exclusive interview with Dexcom CEO Jake Leach (CNBC TV)
07:51AM	JPM26: Dexcoms new CEO eyes international CGM markets for 2026 growth (Medical Device Network)
Jan-12-26 01:26PM	Why This Medical Device Company Is the Top Stock in the S&P 500 Today (Barrons.com) +5.31%
07:30AM	Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook (Business Wire)
Jan-09-26 10:45AM	Owlet's Data Flywheel Grows: Can AI Boost Lifetime Value? (Zacks)
Jan-08-26 11:36AM	DexCom (DXCM) Stock Trades Down, Here Is Why (StockStory)
Jan-07-26 04:55PM	Top Stock Reports for Micron Technology, Roche & UnitedHealth (Zacks)
09:00AM	Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer (Business Wire)
Dec-31-25 11:37PM	2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky (StockStory)
Dec-30-25 08:20AM	2 Growth Stocks to Buy For 2026 and Beyond (Motley Fool)
07:33AM	3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium (Zacks)
Dec-26-25 09:00AM	DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM (PR Newswire)
Dec-24-25 11:45AM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
09:45AM	Why DexCom (DXCM) is a Top Growth Stock for the Long-Term (Zacks)
Dec-22-25 08:42AM	Morgan Stanley Upgrades DexCom (DXCM), Cites Undervalued Recovery and G7 Margin Potential (Insider Monkey)
01:50AM	Medtronics diabetes spinoff MiniMed files for IPO (MedTech Dive)
Dec-18-25 10:09AM	DexCom (DXCM) Fell Due to Modest Guidance (Insider Monkey)
Dec-17-25 11:58AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Dec-16-25 09:00AM	Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM (PR Newswire)
Dec-13-25 10:34AM	Jim Cramer on DexCom: "It's Too Rich a Stock" (Insider Monkey)
Dec-11-25 08:32PM	Lightning Round: MercadoLibre is 'such a good company', says Jim Cramer (CNBC TV)
09:40AM	Stock Market Today: Dow Rises On Surprise Jobless Claims Data; Oracle Plunges On Earnings (Live Coverage) (Investor's Business Daily)
07:59AM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM (PR Newswire)
Dec-09-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-08-25 09:45AM	DexCom (DXCM) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Dec-05-25 02:29PM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Dec-04-25 08:02AM	Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy (Business Wire)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
07:59AM	Is DexCom Stock Underperforming the S&P 500? (Barchart)
Dec-02-25 12:10PM	DexCom Stock Upgraded. How the Glucose Monitor Maker Is 'Turning a Corner.' (Barrons.com)
09:34AM	Teradyne upgraded, Circle Internet initiated: Wall Street's top analyst calls (The Fly)
Dec-01-25 04:11AM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM (PR Newswire)
Nov-30-25 03:34PM	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-27-25 08:13AM	Here's Why Dexcom (DXCM) Traded Down in Q3 (Insider Monkey)
Nov-25-25 09:17AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More (24/7 Wall St.)
08:27AM	Morgan Stanley, Truist Cautious on DexCom (DXCM) Cites Weaker Gross Margins, Modest Q3 Beat (Insider Monkey)
07:50AM	Carillon Eagle Mid Cap Growth Fund's Views on Dexcom (DXCM) (Insider Monkey)
Nov-23-25 10:28AM	2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon (Motley Fool)
Nov-21-25 08:15AM	Top 2 Healthcare Stocks Every New Investor Should Know (Motley Fool)
01:33AM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM (PR Newswire)
Nov-20-25 09:45AM	Here's Why DexCom (DXCM) is a Strong Growth Stock (Zacks)
09:16AM	DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal (Zacks)
08:30AM	Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States (Business Wire)
Nov-19-25 08:30AM	Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes (Business Wire)
Nov-17-25 11:01PM	3 Reasons We're Fans of DexCom (DXCM) (StockStory)
Nov-14-25 09:32AM	Aristotle Atlantic's Core Equity Strategy Initiated a Position in Dexcom (DXCM) Backed by Its Robust Financial Stability (Insider Monkey)
08:00AM	Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day (Business Wire)
Nov-13-25 06:43PM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights DXCM (Business Wire)
01:02PM	Frank Sands Reduces Stake in DexCom Inc by 50.4%, Impacting Portfolio by -1.25% (GuruFocus.com)
12:06PM	The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout (Investor's Business Daily)
06:39AM	DexCom Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-12-25 10:32PM	Winners And Losers Of Q3: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks (StockStory)
12:52PM	Whoop Is Considering Going Public in the Next Two Years, CEO Says (Bloomberg)
09:45AM	Big Insider Purchases by Carl Icahn, Mario Gabelli, and Others (24/7 Wall St.)
07:15AM	DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price? (Motley Fool)
Nov-11-25 12:44PM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks) +6.00%
10:23AM	1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street (Motley Fool)
09:45AM	Stock Market Today: Dow Rises After Shutdown Bill Passes; Nvidia Partner Plunges (Live Coverage) (Investor's Business Daily)
09:18AM	Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately (PR Newswire)
Nov-07-25 04:00PM	DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM (PR Newswire) -5.21%
Nov-06-25 08:34PM	Quebec Expands Access to Dexcom CGM under the Regie de l'assurance maladie du Quebec (RAMQ) (Business Wire)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Heller Bridgette P	Director	Feb 12 '26	Proposed Sale	68.01	1,012	68,826		Feb 12 09:51 AM
Collins Richard Alexander	Director	Nov 14 '25	Sale	59.05	2,906	171,599	35,088	Nov 17 05:52 PM
Collins Richard Alexander	Director	Nov 14 '25	Proposed Sale	59.05	2,906	171,599		Nov 14 09:50 AM
Heller Bridgette P	Director	Nov 12 '25	Sale	58.07	1,012	58,767	27,031	Nov 12 05:14 PM
Heller Bridgette P	Director	Nov 12 '25	Proposed Sale	58.07	1,012	58,767		Nov 12 10:52 AM
Leach Jacob Steven	President & COO	Nov 10 '25	Buy	55.04	18,200	1,001,702	331,697	Nov 10 07:13 PM
Collins Richard Alexander	Director	Nov 10 '25	Sale	55.17	3,948	217,811	37,994	Nov 10 07:12 PM
Collins Richard Alexander	Director	Nov 10 '25	Proposed Sale	55.17	3,948	217,811		Nov 10 09:52 AM
Malady Kyle	Director	Sep 05 '25	Sale	80.86	667	53,934	22,667	Sep 09 04:18 PM
Stern Sadie	EVP, Chief HR Officer	Sep 04 '25	Sale	80.00	1,466	117,280	105,223	Sep 08 04:06 PM
Malady Kyle	Director	Sep 05 '25	Proposed Sale	80.86	667	53,934		Sep 05 11:08 AM
SADIE STERN	Officer	Sep 04 '25	Proposed Sale	80.00	1,466	117,280		Sep 04 04:29 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 02 '25	Sale	74.17	4,824	357,796	118,657	Sep 04 04:13 PM
JEREME SYLVAIN	Officer	Sep 02 '25	Proposed Sale	74.17	4,824	357,796		Sep 02 04:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 15 '25	Sale	80.29	500	40,145	94,102	Aug 18 05:56 PM
FOLETTA MARK G	Director	Aug 15 '25	Sale	81.06	2,750	222,903	51,121	Aug 18 05:53 PM
MICHAEL BROWN	Officer	Aug 15 '25	Proposed Sale	80.29	500	40,145		Aug 15 04:57 PM
FOLETTA MARK G	Director	Aug 15 '25	Proposed Sale	80.29	2,750	220,798		Aug 15 04:04 PM
Stern Sadie	EVP, Chief HR Officer	Jul 28 '25	Sale	88.99	1,466	130,459	106,689	Jul 29 04:18 PM
SADIE STERN	Officer	Jul 28 '25	Proposed Sale	88.99	1,466	130,459		Jul 28 04:29 PM
FOLETTA MARK G	Director	Jul 15 '25	Sale	85.17	2,750	234,217	53,871	Jul 17 04:08 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 15 '25	Sale	86.03	500	43,015	94,602	Jul 17 04:03 PM
MICHAEL BROWN	Officer	Jul 15 '25	Proposed Sale	86.03	500	43,015		Jul 15 04:11 PM
FOLETTA MARK G	Director	Jul 15 '25	Proposed Sale	86.03	2,750	236,582		Jul 15 04:02 PM
Stern Sadie	EVP, Chief HR Officer	Jun 26 '25	Sale	85.06	1,466	124,698	108,155	Jun 30 06:47 PM
SADIE STERN	Officer	Jun 26 '25	Proposed Sale	85.06	1,466	124,698		Jun 26 04:04 PM
FOLETTA MARK G	Director	Jun 16 '25	Sale	83.13	2,750	228,605	56,621	Jun 18 04:31 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jun 16 '25	Sale	82.80	500	41,400	95,102	Jun 18 04:31 PM
AUGUSTINOS NICHOLAS	Director	Jun 16 '25	Sale	82.80	3,672	304,042	33,411	Jun 17 05:33 PM
AUGUSTINOS NICHOLAS	Director	Jun 13 '25	Sale	81.69	2,618	213,864	37,083	Jun 17 05:33 PM
MICHAEL BROWN	Officer	Jun 16 '25	Proposed Sale	82.80	500	41,400		Jun 16 04:12 PM
FOLETTA MARK G	Director	Jun 16 '25	Proposed Sale	82.80	2,750	227,700		Jun 16 04:02 PM
AUGUSTINOS NICHOLAS	Director	Jun 09 '25	Proposed Sale	86.91	6,290	546,664		Jun 09 03:59 PM
Stern Sadie	EVP, Chief HR Officer	May 27 '25	Sale	85.11	6,184	526,318	109,621	May 28 04:51 PM
Brown Michael Jon	EVP, Chief Legal Officer	May 23 '25	Sale	84.28	10,000	842,849	95,602	May 28 04:50 PM
SADIE STERN	Officer	May 27 '25	Proposed Sale	85.11	6,184	526,318		May 27 04:18 PM
MICHAEL BROWN	Officer	May 23 '25	Proposed Sale	84.28	10,000	842,849		May 23 04:04 PM
Heller Bridgette P	Director	Mar 17 '25	Sale	70.33	352	24,756	22,997	Mar 19 05:02 PM
Heller Bridgette P	Director	Mar 17 '25	Proposed Sale	70.33	352	24,756		Mar 17 09:40 AM
Leach Jacob Steven	EVP, Chief Operating Officer	Mar 12 '25	Sale	70.38	14,076	990,670	313,497	Mar 14 05:25 PM
Brown Michael Jon	EVP, Chief Legal Officer	Mar 12 '25	Sale	70.38	13,000	914,941	105,602	Mar 14 05:25 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 12 '25	Sale	70.38	12,001	844,632	123,481	Mar 14 05:25 PM
Stern Sadie	EVP, Chief HR Officer	Mar 12 '25	Sale	70.38	11,176	786,568	115,805	Mar 14 05:25 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 12 '25	Sale	70.38	32,498	2,287,212	372,029	Mar 14 05:24 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 10 '25	Sale	73.83	7,000	516,830	135,482	Mar 11 07:17 PM
JEREME SYLVAIN	Officer	Mar 10 '25	Proposed Sale	73.83	7,000	516,830		Mar 10 04:03 PM

IRTC

iRhythm Holdings Inc

DXCM

Dexcom Inc

Upgrade your FINVIZ experience